Thrivent Financial for Lutherans’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-45,976
| Closed | -$184K | – | 2323 |
|
|
2019
Q4 | $184K | Buy |
45,976
+516
| +1% | +$2.42K | ﹤0.01% | 2175 |
|
|
2019
Q3 | $223K | Buy |
45,460
+1,055
| +2% | +$5.9K | ﹤0.01% | 2111 |
|
|
2019
Q2 | $270K | Buy |
44,405
+1,198
| +3% | +$6.37K | ﹤0.01% | 2055 |
|
|
2019
Q1 | $251K | Buy |
43,207
+3,783
| +10% | +$39.1K | ﹤0.01% | 2058 |
|
|
2018
Q4 | $531K | Buy |
39,424
+867
| +2% | +$14.6K | ﹤0.01% | 1525 |
|
|
2018
Q3 | $748K | Buy |
38,557
+5,501
| +17% | +$117K | ﹤0.01% | 1465 |
|
|
2018
Q2 | $845K | Buy |
33,056
+629
| +2% | +$14.7K | ﹤0.01% | 1367 |
|
|
2018
Q1 | $653K | Buy |
32,427
+2,589
| +9% | +$60.4K | ﹤0.01% | 1487 |
|
|
2017
Q4 | $599K | Buy |
29,838
+588
| +2% | +$11.6K | ﹤0.01% | 1574 |
|
|
2017
Q3 | $606K | Buy |
29,250
+2,980
| +11% | +$50.4K | ﹤0.01% | 1465 |
|
|
2017
Q2 | $389K | Sell |
26,270
-284,310
| -92% | -$4.74M | ﹤0.01% | 1646 |
|
|
2017
Q1 | $4.95M | Buy |
310,580
+46,690
| +18% | +$673K | 0.02% | 585 |
|
|
2016
Q4 | $3.33M | Buy |
263,890
+241,760
| +1,092% | +$4.5M | 0.01% | 714 |
|
|
2016
Q3 | $620K | Buy |
22,130
+4,610
| +26% | +$155K | ﹤0.01% | 1361 |
|
|
2016
Q2 | $613K | Buy |
17,520
+780
| +5% | +$24.5K | ﹤0.01% | 1324 |
|
|
2016
Q1 | $459K | Buy |
+16,740
| New | +$493K | ﹤0.01% | 1405 |
|
Other funds holding DPLO
Thrivent Financial for Lutherans's DPLO Position: Q1 2020 in Review
Thrivent Financial for Lutherans sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q1 2020, closing a stake of 45,976 shares — an estimated $184K sold.
Thrivent Financial for Lutherans first reported a position in DPLO in Q1 2016 and held it in 16 quarters. The position peaked at $4.95M in Q1 2017. 1 fund tracked by Wall St. Rank holds DPLO as of Q1 2020.
- Thrivent Financial for Lutherans reported no remaining DIPLOMAT PHARMACY, INC. position as of Q1 2020 after selling out during the quarter.
- Thrivent Financial for Lutherans sold 45,976 DIPLOMAT PHARMACY, INC. shares in Q1 2020, an estimated $184K.
- Thrivent Financial for Lutherans first reported a position in DIPLOMAT PHARMACY, INC. in Q1 2016 and held it in 16 quarters.
- Thrivent Financial for Lutherans's DIPLOMAT PHARMACY, INC. position peaked at $4.95M in Q1 2017.
- 1 fund tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q1 2020.
Based on Thrivent Financial for Lutherans's 13F filing for Q1 2020, filed 15 May 2020.